The Frontal Assessment Battery (FAB) has been used in different clinical settings as a valuable quick bedside test for executive dysfunction. The aim of the study was to evaluate clinical utility of the FAB for differential diagnosis of Alzheimer disease (AD), subcortical vascular cognitive impairment (scVCI), and frontotemporal lobar degeneration (FTLD).
Methods:
Scores of the total FAB test and subtests were compared between consecutive series of 37 patients with AD, 31 patients with scVCI, 13 patients with FTLD, and 29 cognitively healthy individuals.
Results:
There was no statistically significant difference in the total FAB scores among the groups of patients with dementia. When comparing subtest scores, patients with FTLD had significantly lower scores on the lexical fluency subtest compared to the patients with AD (P < .001) or scVCI (P < .001); patients with scVCI had significantly lower scores on the motor series subtest compared to patients with FTLD (P = .02) and AD (P = .035) and on conflicting instructions subtest compared to patients with AD (P = .033).
Conclusion:
Some FAB subtests might enhance diagnostic accuracy taking into account clinical history and other tests of executive function.
AlmkvistOBäckmanLBasunHWahlundLO. Patterns of neuropsychological performance in Alzheimer's disease and vascular dementia. Cortex. 1993;29(4):661–673.
3.
PerryRJHodgesJR. Attention and executive deficits in Alzheimer's disease. A critical review. Brain. 1999;122(pt 3):383–404.
4.
PerryRJWatsonPHodgesJR. The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment. Neuropsychologia. 2000;38(3):252–271.
5.
GiovagnoliARErbettaAReatiFBugianiO. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance. Neuropsychologia. 2008;46(5):1495–1504.
6.
ReedBRMungasDMKramerJH. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain. 2007;130(pt 3):731–739.
7.
ThompsonJCStopfordCLSnowdenJSNearyD. Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2005;76(7):920–927.
8.
KramerJHJurikJShaSJ. Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cogn Behav Neurol. 2003;16(4):211–218.
FolsteinMFFolsteinSEMcHughPR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
11.
NelsonHE. A modified card sorting test sensitive to frontal lobe defects. Cortex. 1976;12(4):313–324.
12.
PerretE. The left frontal lobe of man and the suppression of habitual responses in verbal categorical behaviour. Neuropsychologia. 1974;12(3):323–330.
13.
DuboisBSlachevskyALitvanPillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55(11):1621–1626.
14.
LiptonAMOhmanKAWomackKBHynanLSNinmanETLacritzLH. Subscores of the FAB differentiate frontotemporal lobar degeneration from AD. Neurology. 2005;65(5):726–731.
15.
PaviourDCWinterburnDSimmondsS. Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing. Neurocase. 2005;11(4):274–282.
16.
OguroHYamaguchiSAbeSIshidaYBokuraHKobayashiS. Differentiating Alzheimer's disease from subcortical vascular dementia with the FAB test. J Neurol. 2006;253(11):1490–1494.
17.
MokVCWongAYimP. The validity and reliability of chinese frontal assessment battery in evaluating executive dysfunction among Chinese patients with small subcortical infarct. Alzheimer Dis Assoc Disord. 2004;18(2):68–74.
18.
FukuiTLeeEKitamuraM. Visuospatial dysfunction may be a key in the differentiation between Alzheimer's disease and subcortical cognitive impairment in moderate to severe stages. Dement Geriatr Cogn Disord. 2009;28(4):288–294.
19.
McKhannGDrachmanDFolsteinMKatzmanRPriceDStadlanEM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939–944.
20.
NearyDSnowdenJSGustafsonL. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546–1554.
21.
RománGCTatemichiTKErkinjunttiT. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250–260.
22.
BobanMMalojčićBMimicaN. The reliability and validity of the mini-mental state examination in the elderly croatian population. Dement Geriatr Cogn Disord. 2012;33(6):385–392.
23.
IavaroneARongaBPellegrinoL. The Frontal Assessment Battery (FAB): normative data from an Italian sample and performances of patients with Alzheimer's disease and frontotemporal dementia. Funct Neurol. 2004;19(3):191–195.
24.
SlachevskyAVillalpandoJMSarazinMHahn-BarmaVPillonBDuboisB. Frontal assessment battery and differential diagnosis of frontotemporal dementia and Alzheimer disease. Arch Neurol. 2004;61(7):1104–1107.
25.
CastiglioniSPelatiOZuffiM. The frontal assessment battery does not differentiate frontotemporal dementia from Alzheimer's disease. Dement Geriatr Cogn Disord. 2006;22(2):125–131.
26.
MoorhousePSongXRockwoodK. Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study. J Neurol Sci. 2010;288(1-2):142–146.
27.
SwanbergMMTractenbergREMohsRThalLJCummingsJL. Executive dysfunction in Alzheimer disease. Arch Neurol. 2004;61(4):556–560.
28.
WillisSLAllen-BurgeRDolanMMBertrandRMYesavageJTaylorJL. Everyday problem solving among individuals with Alzheimer's disease. Gerontologist. 1998;38(5):569–577.
29.
KlunkWEEnglerHNordbergA. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55(3):306–319.
30.
ThalDRRübUOrantesMBraakH. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58(12):1791–1800.
31.
GrahamNLEmeryTHodgesJR. Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry. 2004;75(1):61–71.
32.
BraakHBraakE. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging. 1997;18(4):351–357.
33.
UmetsuAOkudaJFujiiT. Brain Activation during the fist-edge-palm test: a functional MRI study. Neuroimage. 2002;17(1):385–392.
